These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26993822)

  • 1. Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy.
    Paul S; Shuja A; Tam I; Kim EM; Kang S; Kapulsky L; Viveiros K; Lee H
    Dig Dis Sci; 2016 Aug; 61(8):2236-2241. PubMed ID: 26993822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving testing for hepatitis B before treatment with rituximab.
    Dyson JK; Jopson L; Ng S; Lowery M; Harwood J; Waugh S; Valappil M; McPherson S
    Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1172-8. PubMed ID: 27388147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network.
    Kwak YE; Stein SM; Lim JK
    Dig Dis Sci; 2018 Jan; 63(1):61-71. PubMed ID: 29177849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists.
    Shah R; Ho EY; Kramer JR; Richardson P; Sansgiry S; El-Serag HB; Hou JK
    Dig Dis Sci; 2018 Jun; 63(6):1551-1557. PubMed ID: 29663266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases.
    Artz AS; Somerfield MR; Feld JJ; Giusti AF; Kramer BS; Sabichi AL; Zon RT; Wong SL
    J Clin Oncol; 2010 Jul; 28(19):3199-202. PubMed ID: 20516452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of hepatitis B reactivation in patients receiving anti-tumor necrosis factor-α therapy.
    Fidan S; Capkın E; Arıca DA; Durak S; Okatan IE
    Int J Rheum Dis; 2021 Feb; 24(2):254-259. PubMed ID: 33244900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists.
    Pauly MP; Tucker LY; Szpakowski JL; Ready JB; Baer D; Hwang J; Lok AS
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1964-1973.e1. PubMed ID: 29702293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatologists' awareness of and screening practices for hepatitis B virus infection before initiating tumor necrosis factor-α inhibitor therapy.
    Stine JG; Bass M; Ibrahim D; Khokhar OS; Lewis JH
    South Med J; 2011 Dec; 104(12):781-8. PubMed ID: 22089354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening practices for hepatitis B virus prior to viral reactivation risk therapies among different medical specialties. HEBRA Project].
    García-Bengoechea M; Hernández-López C; Crespo J; Gea F;
    Med Clin (Barc); 2012 Nov; 139(11):498-501. PubMed ID: 22982126
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for tuberculosis and hepatitis B prior to the initiation of anti-tumor necrosis therapy.
    Vaughn BP; Doherty GA; Gautam S; Moss AC; Cheifetz AS
    Inflamm Bowel Dis; 2012 Jun; 18(6):1057-63. PubMed ID: 21953829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatologists' awareness of hepatitis B reactivation before immunosuppressive therapy.
    Toka B; Eminler AT; Gönüllü E; Tozlu M; Uslan MI; Parlak E; Karabay O; Koksal AS
    Rheumatol Int; 2019 Dec; 39(12):2077-2085. PubMed ID: 31520109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial minorities are more likely than whites to report lack of provider recommendation for colon cancer screening.
    May FP; Almario CV; Ponce N; Spiegel BM
    Am J Gastroenterol; 2015 Oct; 110(10):1388-94. PubMed ID: 25964227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvements in hepatitis B virus screening before rituximab therapy: A community-based, safety-net hospital experience.
    Junus K; Aguilar M; Patel P; Irwin D; Yee S; Liu B; Bhuket T; Wong RJ
    Cancer; 2017 Feb; 123(4):650-656. PubMed ID: 27696389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low rates of hepatitis B virus screening at the onset of chemotherapy.
    Hwang JP; Fisch MJ; Zhang H; Kallen MA; Routbort MJ; Lal LS; Vierling JM; Suarez-Almazor ME
    J Oncol Pract; 2012 Jul; 8(4):e32-9. PubMed ID: 23180996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy--a report of long-term follow-up of serial cases and literature review.
    Xuan D; Yu Y; Shao L; Wang J; Zhang W; Zou H
    Clin Rheumatol; 2014 Apr; 33(4):577-86. PubMed ID: 24343455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for viral hepatitis prior to rituximab chemotherapy.
    Leonard AN; Love BL; Norris LB; Siddiqui SK; Wallam MN; Bennett CL
    Ann Hematol; 2016 Jan; 95(1):27-33. PubMed ID: 26382277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
    Hwang JP; Suarez-Almazor ME; Cantor SB; Barbo A; Lin HY; Ahmed S; Chavez-MacGregor M; Donato-Santana C; Eng C; Ferrajoli A; Fisch MJ; McLaughlin P; Simon GR; Rondon G; Shpall EJ; Lok AS
    Cancer; 2017 Sep; 123(17):3367-3376. PubMed ID: 28518219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.
    Méndez-Navarro J; Corey KE; Zheng H; Barlow LL; Jang JY; Lin W; Zhao H; Shao RX; McAfee SL; Chung RT
    Liver Int; 2011 Mar; 31(3):330-9. PubMed ID: 20738779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for hepatitis B in chemotherapy patients: survey of current oncology practices.
    Tran TT; Rakoski MO; Martin P; Poordad F
    Aliment Pharmacol Ther; 2010 Jan; 31(2):240-6. PubMed ID: 19814747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.